FLT3 and acute myeloid leukemia: In the present study, we used data from The Cancer Genome Atlas (TCGA) available at UALCAN (http://ualcan/path.uab.edu/, accessed on 29 July 2021) and Gene Expression Profiling Interactive Analysis 2 (GEPIA2) (http://gepia2.cancer-pku.cn/, accessed on 2 August 2021) to analyze the expression of non-ATPase subunits of the 19S proteasome (Table 1) in patients with FLT3-mutated AML.